Status:
COMPLETED
Comparison of SPECT/CT Perfusion and Volumetric CT Volume
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Lung Cancer (NSCLC)
Eligibility:
All Genders
18-95 years
Brief Summary
The main aim of this study is to show that single photon emission tomography/Computer tomography (SPECT/CT) is a reliable examination to predict postoperative pulmonary function after segmentectomy, b...
Detailed Description
Lung cancer has a high prevalence, incidence and mortality in France and worldwide. Surgical treatment, possible only at an early stage, improves the prognosis of patients. In addition, the increasing...
Eligibility Criteria
Inclusion
- Person having received full information on the organization of the research and not having opposed the exploitation of this data
- Patients having benefited from a single or multiple segmentectomy within the thoracic surgery department of the CHRU of Nancy during the period April 2021 to June 2023
- Patients having a complete pre-operative assessment (SPECT/CT, volumetric CT and EFR)
- Patients having 2 post-operative assessments (respiratory functional exploration (EFR) at approximately 1 month post-operatively and 6 months post-operatively).
Exclusion
- Patients who underwent more extensive surgery (lobectomy, pneumectomy) or less extensive surgery (wedge).
- Patient who did not have a complete preoperative assessment (SPECT/CT or volumetric CT or missing respiratory functional exploration EFR).
- Patient who did not have a complete postoperative assessment (missing respiratory functional exploration EFR at 6 months).
- NB: the absence of respiratory functional exploration EFR at 1 month postoperatively is not an exclusion criterion
Key Trial Info
Start Date :
November 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06600204
Start Date
November 30 2024
End Date
June 1 2025
Last Update
June 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU of NANCY
Vandœuvre-lès-Nancy, France, 54511